Morrone Louis H.
SEC CIK 1867666 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | SVP | 0 | — | $5.57M | 29 | 2021-07-01 | 2026-08-12 |
Most active insiders at ABT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ford Robert B | COB AND CEO, Dir | $2.01M | $46.20M |
| 2 | STARKS DANIEL J | Dir | $2.01M | — |
| 3 | Morrone Louis H. | EVP | — | $774.7K |
| 4 | Shroff Eric | SVP | — | $285.0K |
| 5 | Boudreau Philip P | EVP AND CFO | $201.3K | — |
| 6 | Stratton John G | Dir | $173.6K | — |
| 7 | Salvadori Daniel Gesua Sive | EVP AND GROUP Pres | — | $102.3K |
| 8 | Moreland Mary K | EVP | — | $70.9K |
| 9 | MCCOY JOHN A. JR. | VP AND Ctrl | — | $70.6K |
| 10 | Cushman Elizabeth C. | EVP, GC AND Sec | — | $30.4K |
Transactions 29
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 17:14 | 2026-08-11 | ABT | Abbott Laboratories | Morrone Louis H. | EVP | S - Sale | $109.83 | -5,850 | 70.7K | -8% | -$642.5K | |
| I | 2026-08-13 17:14 | 2026-08-12 | ABT | Abbott Laboratories | Morrone Louis H. | EVP | I - Discretionary | $107.99 | -12 | 0 | -100% | -$1,296 |
| 2026-07-01 17:04 | 2026-06-30 | ABT | Abbott Laboratories | Morrone Louis H. | EVP | F - Tax | $92.71 | -269 | 76.6K | -0.4% | -$24.9K | |
| 2026-03-03 | 2026-02-27 | ABT | Abbott Laboratories | Morrone Louis H. | EVP | F - Tax | $116.26 | -4,040 | 78.0K | -5% | -$469.7K | |
| 2026-03-03 | 2026-03-02 | ABT | Abbott Laboratories | Morrone Louis H. | EVP | S - Sale | $115.58 | -1,144 | 76.8K | -1% | -$132.2K | |
| D | 2026-02-26 | 2026-02-24 | ABT | Abbott Laboratories | Morrone Louis H. | EVP | A - Grant | $0.00 | +15.4K | 82.0K | +23% | $0 |
| 2025-07-01 | 2025-06-30 | ABT | Abbott Laboratories | Morrone Louis H. | EVP | F - Tax | $134.38 | -269 | 66.6K | -0.4% | -$36.1K | |
| 2025-03-04 | 2025-02-28 | ABT | Abbott Laboratories | Morrone Louis H. | EVP | F - Tax | $135.87 | -4,386 | 68.0K | -6% | -$595.9K | |
| 2025-03-04 | 2025-03-03 | ABT | Abbott Laboratories | Morrone Louis H. | EVP | S - Sale | $138.17 | -1,111 | 66.9K | -2% | -$153.5K | |
| D | 2025-02-27 | 2025-02-25 | ABT | Abbott Laboratories | Morrone Louis H. | EVP | A - Grant | $0.00 | +10.2K | 72.4K | +16% | $0 |
| I | 2025-01-30 | 2025-01-28 | ABT | Abbott Laboratories | Morrone Louis H. | EVP | S - Sale | $127.39 | -2,644 | 0 | -100% | -$336.8K |
| M | 2024-07-02 | 2024-06-30+ | ABT | Abbott Laboratories | Morrone Louis H. | EVP | F - Tax | $103.91 | -825 | 62.1K | -1% | -$85.7K |
| 2024-03-04 | 2024-02-29 | ABT | Abbott Laboratories | Morrone Louis H. | EVP | F - Tax | $120.05 | -3,455 | 63.8K | -5% | -$414.8K | |
| 2024-03-04 | 2024-03-01 | ABT | Abbott Laboratories | Morrone Louis H. | EVP | S - Sale | $118.50 | -801 | 63.0K | -1% | -$94.9K | |
| D | 2024-02-23 | 2024-02-21 | ABT | Abbott Laboratories | Morrone Louis H. | EVP | A - Grant | $0.00 | +12.3K | 67.2K | +22% | $0 |
| D | 2023-07-05 | 2023-06-30 | ABT | Abbott Laboratories | Morrone Louis H. | EVP | A - Grant | $0.00 | +1,815 | 55.5K | +3% | $0 |
| D | 2023-07-05 | 2023-07-01 | ABT | Abbott Laboratories | Morrone Louis H. | EVP | F - Tax | $109.02 | -556 | 54.9K | -1% | -$60.6K |
| 2023-03-02 | 2023-02-28 | ABT | Abbott Laboratories | Morrone Louis H. | SVP | F - Tax | $99.77 | -2,534 | 54.7K | -4% | -$252.8K | |
| 2023-03-02 | 2022-03-01 | ABT | Abbott Laboratories | Morrone Louis H. | SVP | S - Sale | $100.70 | -1,092 | 53.7K | -2% | -$110.0K | |
| D | 2023-02-22 | 2023-02-17 | ABT | Abbott Laboratories | Morrone Louis H. | SVP | A - Grant | $0.00 | +10.6K | 57.3K | +23% | $0 |
| 2022-07-01 | 2022-07-01 | ABT | Abbott Laboratories | Morrone Louis H. | SVP | F - Tax | $108.65 | -556 | 46.7K | -1% | -$60.4K | |
| 2022-03-02 | 2022-02-28 | ABT | Abbott Laboratories | Morrone Louis H. | SVP | F - Tax | $122.41 | -1,942 | 47.9K | -4% | -$237.7K | |
| 2022-03-02 | 2022-03-01 | ABT | Abbott Laboratories | Morrone Louis H. | SVP | S - Sale | $118.16 | -656 | 47.3K | -1% | -$77.5K | |
| D | 2022-02-23 | 2022-02-18 | ABT | Abbott Laboratories | Morrone Louis H. | SVP | A - Grant | $0.00 | +11.6K | 49.9K | +30% | $0 |
| D | 2021-12-21 | 2021-12-17 | ABT | Abbott Laboratories | Morrone Louis H. | SVP | S - Sale+OE | $137.54 | -9,988 | 38.2K | -21% | -$1.37M |
| D | 2021-12-21 | 2021-12-17 | ABT | Abbott Laboratories | Morrone Louis H. | SVP | M - OptEx | $48.34 | +9,988 | 48.2K | +26% | +$482.8K |
| DM | 2021-12-08 | 2021-12-06+ | ABT | Abbott Laboratories | Morrone Louis H. | SVP | S - Sale+OE | $132.50 | -20.0K | 38.2K | -34% | -$2.65M |
| DM | 2021-12-08 | 2021-12-06+ | ABT | Abbott Laboratories | Morrone Louis H. | SVP | M - OptEx | $48.34 | +20.0K | 48.2K | +71% | +$965.7K |
| D | 2021-07-06 | 2021-07-01 | ABT | Abbott Laboratories | Morrone Louis H. | SVP | A - Grant | $0.00 | +3,764 | 38.2K | +11% | $0 |
Purchase Sale Sale after option exercise All abbreviations